Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Baclofen Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Baclofen Treatment Report

See also: Baclofen Intrathecal, Lioresal Intrathecal

What is Baclofen? Baclofen is a skeletal muscle relaxant and antispastic agent used for the treatment of reversible spasticity associated with multiple sclerosis or spinal cord lesions.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

37 patients in the community are taking or have taken Baclofen.

Reason # Patients Percentage of patients
Stiffness/Spasticity 13 35%
Treat Parkinson's 6 16%
Other 5 13%
Muscle cramping, spasms 1 2%
disease-related symptoms 1 2%
Muscle spasms 1 2%
Mobility 1 2%
distonia especially foor/toes drawing in 1 2%
Muscle Pain 1 2%

Dosages

Based on the patients currently taking Baclofen.

  daily 0.1 mg daily 0.15 mg daily 10 mg daily 20 mg daily 30 mg daily 40 mg daily 50 mg daily 60 mg daily 80 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 7 Number of Patients: 7 6 Number of Patients: 6 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1  

Duration

How long current patients have been taking Baclofen or how long patients were taking Baclofen before stopping.

Currently Taking Baclofen

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
2
5
4
4

Stopped Taking Baclofen

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
1
2
1
2
3
Why Patients Stopped Taking Baclofen (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 5 42% Did not seem to work: 42%
Side effects too severe 3 25% Side effects too severe: 25%
Doctor's advice 2 17% Doctor's advice: 17%
Other 2 17% Other: 17%
Not indicated 2 17% Not indicated: 17%
Course of treatment ended 1 8% Course of treatment ended: 8%

Report created on November 08, 2009.